
- /
- Supported exchanges
- / US
- / FTRE.NASDAQ
Fortrea Holdings Inc. (FTRE NASDAQ) stock market data APIs
Fortrea Holdings Inc. Financial Data Overview
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I " IV clinical trial management, clinical pharmacology, and consulting services. Fortrea Holdings Inc. enters into a strategic collaboration with Emery Pharma to provide rapid lot-by-lot, 1-methyl-4-nitrosopiperazine (MNP) testing of rifampin, the preferred drug for drug-drug interaction studies, to certify impurities are below the Acceptable Intake Limit set by U.S. Food and Drug Administration guidelines. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Fortrea Holdings Inc. data using free add-ons & libraries
Get Fortrea Holdings Inc. Fundamental Data
Fortrea Holdings Inc. Fundamental data includes:
- Net Revenue: 2 686 M
- EBITDA: -19 600 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-12
- EPS/Forecast: -0.0573
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Fortrea Holdings Inc. News

Fortrea Holdings Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. August 1, 2025 Deadline to file Lead Plaintiff Motion
LOS ANGELES, July 18, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fortrea Holdings Inc. ("Fortrea" or the "Company") (NASDAQ: FTRE) investors of a class action representing investors that ...


Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know
What Happened? A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with...

Levi & Korsinsky Reminds Fortrea Holdings Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 1, 2025 – FTRE
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fortrea Holdings Inc. ("Fortrea Holdings Inc." or the "Company") (NASDAQ: FTRE) of a class action securities l...

FTRE DEADLINE: ROSEN, A TOP-RANKED LAW FIRM, Encourages Fortrea Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – FTRE
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fortrea Holdings, Inc. (NASDAQ: FTRE) between July 3, 2023 an...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.